Redesigning the exhibit provided an opportunity to consider how to best honor and commemorate Rockefeller award winners. Discussions with university leadership and an ad-hoc faculty committee steered the process and led to a broadening of the criteria for inclusion.
The joint program between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center will be lead by Hsu, an accomplished physician-scientist who specializes in immunology research and treatment of blood cancers.
Kreek conducted landmark studies that led to the establishment of methadone as a treatment for heroin addiction. Her work not only yielded new treatments for addiction disorders, but also influenced societal attitudes toward them. She was 84.
The university has named its next vice president and chief investment officer. Volent, who for decades oversaw investments at Bowdoin College, will assume stewardship of Rockefeller's endowment in August.